Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 412 results for "leiden international"

Product Assurance Engineer - Space Industry / Modis / Leiden, ...

I am currently seeking an experienced Product Assurance Engineer to work with my client on an interesting space project in The Netherlands. Some key information regarding the position is as follows: Rate: Up to €70ph Duration: 6 months (with ... GigaOM, 2 days ago

IXYS Corporation Announces Results for the December 2015 Quarter

LEIDEN, Netherlands & MILPITAS, Calif.--( BUSINESS WIRE )--IXYS Corporation (NASDAQ:IXYS), an international power semiconductor and IC company, today reported results for its third quarter of fiscal year 2016, which ended December 31, 2015. Net ...
 Business Wire4 days ago

International Institute for Asian Studies | research fellowship call

The International Institute for Asian Studies (IIAS) in Leiden, Netherlands invites outstanding researchers from around the world to apply for a fellowship to work on an important piece of Asian studies research in the social sciences and ...
 Culture360.org1 month ago IIAS Fellowship  Australian Institute of International Affairs3 weeks ago
Washington Post

Here are 4 reasons why Mozambique isn't a post-war success story

Last month, Mozambique and the international community celebrated an important achievement: The southern African nation was declared landmine-free . This took more than 20 years after the end of a civil war that ravaged the country between ...
 Washington Post4 days ago
Japan Times

Despite poverty, sanctions North Korea nuclear program thrives with low-cost labor

SEOUL North Korea has developed a nuclear weapons program despite poverty and international sanctions, using home-grown technology and virtually free labor to cut costs, experts said. An analysis by the South Korean government has put North ...
 Japan Times3 weeks ago North Korea saves on nukes  Reuters3 weeks ago N Korea overcomes poverty, sanctions with cut-price nukes  The Nation Pakistan3 weeks ago N. Korea Overcomes Poverty Sanctions With Cut-Price Nukes  Singapore Star.com3 weeks ago

Landbouwkundig ontwikkelingsdeskundige leidt CNFA Europa

Nieuwe Europese leider heeft ervaring in de openbare en privé sector BRUSSEL , 13 januari 2016 /PRNewswire/ -- Cultivating New Frontiers in Agriculture (CNFA) heeft Keith Polo , deskundige op het gebied van de internationaal landbouwkundige ...
 PR Newswire3 weeks ago

Mimetas and Partners receive 16 Million Dollar industry funding for development of OrganOnAChip Neurotoxicity Models

Tuesday, December 22, 2015 Leiden-based biotechnology company Mimetas has received 1.6 million USD funding for development of an organ-on-a-chip model for neurotoxicity. The aim of the project is to improve existing neurotoxicity tests and to ...
 Pharma Focus Asia1 month ago Mimetas and Partners Receive 1.6 Million Dollar Industry Funding for Development of Organ-On-A-Chip  CPhI.cn1 month ago
Space News

Op-ed | International Perspectives on Space Resource Rights

Moon Express's MX-1 lander. Credit: Moon Express artist's concept On Nov. 25, U.S. President Barack Obama signed historic legislation into law supporting entrepreneurs with aspirations of economic ventures beyond Earth orbit. The Space Resource ...
 Space News2 months ago

Kite Pharma and Leiden University Medical Center Sign Research and License Agreement for T Cell Receptors Targeting HPV-Associated Cancers

SANTA MONICA, Calif., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. ( Nasdaq:KITE ) today announced that its European subsidiary has entered into a research and license agreement with Leiden University Medical Center (LUMC) to identify and ...
 BioSpace3 weeks ago KITE PHARMA : and Leiden University Medical Center Sign Research and License Agreement for T Cell Receptors Targeting HPV-Associated Cancers  4 Traders3 weeks ago

Pharming Announces Completion of Patient Enrollment in Clinical Study of RUCONEST® for Prophylaxis of Hereditary Angioedema

LEIDEN, the Netherlands, January 6, 2016 /PRNewswire/ — Pharming Group N.V. (Pharming or the Company) (EURONEXT: PHARM) today announced the successful completion of patient enrolment in the Phase 2 clinical study of RUCONEST ® (recombinant C1 ...
 PharmaVOICE4 weeks ago Pharming and Hyupjin Announce Receipt of the South Korean Marketing Authorisation for RUCONEST®  AndhraNews.net1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less